New hib vaccine shows promise in infant trial
NCT ID NCT02140047
First seen Jan 07, 2026 · Last updated Apr 29, 2026 · Updated 20 times
Summary
This study tested a new vaccine called MT-2301 in 154 healthy infants to see if it protects against Haemophilus influenzae type b (Hib) disease. The vaccine was given along with routine childhood shots, and its effects were compared to an existing Hib vaccine. The goal was to check how well the vaccine works and if it is safe for infants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILUS INFLUENZA TYPE B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Fukuoka, Fukuoka, Japan
Conditions
Explore the condition pages connected to this study.